APRE Stock Forecast 2025-2026
Distance to APRE Price Targets
APRE Price Momentum
🤔 Considering Aprea (APRE)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest APRE Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, APRE has a bullish consensus with a median price target of $16.00 (ranging from $11.00 to $20.00). Currently trading at $2.40, the median forecast implies a 566.7% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Joseph Pantginis at HC Wainwright & Co., projecting a 733.3% upside. Conversely, the most conservative target is provided by Robert Driscoll at Wedbush, suggesting a 358.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
APRE Analyst Ratings
APRE Price Target Range
Latest APRE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for APRE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 15, 2025 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Dec 17, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Nov 18, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Oct 24, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Aug 13, 2024 | Wedbush | Robert Driscoll | Outperform | Reiterates | $11.00 |
| Aug 12, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Jun 24, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Jun 17, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| May 14, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Mar 27, 2024 | Wedbush | Robert Driscoll | Outperform | Maintains | $11.00 |
| Mar 26, 2024 | HC Wainwright & Co. | Joseph Pantginis | Buy | Maintains | $20.00 |
| Nov 1, 2023 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Sep 13, 2023 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Aug 10, 2023 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| May 16, 2023 | HC Wainwright & Co. | Joseph Pantginis | Buy | Reiterates | $20.00 |
| Mar 10, 2023 | Maxim Group | Jason McCarthy | Buy | Initiates | $16.00 |
| Oct 10, 2022 | HC Wainwright & Co. | Joseph Pantginis | Buy | Assumes | $3.00 |
| Jul 8, 2022 | Wedbush | Robert Driscoll | Outperform | Initiates | $3.00 |
| Mar 16, 2022 | HC Wainwright & Co. | Andrew Fein | Neutral | Maintains | $2.00 |
| Mar 16, 2022 | RBC Capital | Gregory Renza | Sector Perform | Maintains | $4.00 |
Clear Creek Independent School District (APRE) Competitors
The following stocks are similar to Aprea based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Clear Creek Independent School District (APRE) Financial Data
Clear Creek Independent School District has a market capitalization of $13.04M with a P/E ratio of 0.5x. The company generates $1.31M in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is +11.0% quarter-over-quarter, while maintaining an operating margin of -1,155.3% and return on equity of -60.2%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Clear Creek Independent School District (APRE) Business Model
About Clear Creek Independent School District
Provides foundational education from K-12.
As a public school district, it generates revenue primarily through state funding, local property taxes, and grants. Its focus on delivering quality education and enhancing student outcomes allows it to maintain strong community support and partnerships, which further bolster its resources.
The district encompasses a diverse range of schools offering specialized programs and extracurricular activities. Clear Creek ISD collaborates with local businesses and higher education institutions to enrich its offerings, demonstrating a commitment to integrating educational technology and adapting to new teaching methodologies.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
7
CEO
Dr. Oren Gilad Ph.D.
Country
United States
IPO Year
2019
Website
www.aprea.comClear Creek Independent School District (APRE) Latest News & Analysis
Aprea Therapeutics (Nasdaq: APRE) has signed a Material Transfer Agreement with MD Anderson Cancer Center to provide its WEE1 kinase inhibitor, APR-1051, for preclinical research on head and neck cancer.
Aprea's MTA with MD Anderson to research APR-1051 may enhance its drug pipeline and validate its approach, potentially boosting stock value and investor confidence.
Aprea Therapeutics (Nasdaq: APRE) announced an update on its patent portfolio, focusing on treatments targeting cancer cell vulnerabilities while preserving healthy cells.
Aprea Therapeutics' update on its patent portfolio could enhance its competitive edge and potential for revenue, influencing stock performance and investor sentiment.
Aprea's experimental drug, ATRN-119, will use a twice-daily dosing regimen to enhance its clinical effectiveness over a 24-hour period.
The BID dosing regimen for ATRN-119 suggests enhanced efficacy, potentially leading to stronger clinical results and increased market interest, positively impacting Aprea's stock value.
Aprea Therapeutics (APRE) has formed a hammer chart pattern, suggesting support. Additionally, upward earnings estimate revisions may indicate a potential trend reversal.
The hammer chart pattern signals potential support for Aprea Therapeutics, suggesting a possible trend reversal, while rising earnings estimates could enhance investor confidence and drive stock prices up.
Aprea Therapeutics (APRE) reported a quarterly loss of $0.64 per share, better than the estimated loss of $0.75, and improved from a loss of $0.86 per share a year ago.
Aprea's smaller-than-expected loss signals improving financial performance, potentially boosting investor confidence and increasing stock value.
The Phase 1 ACESOT-1051 trial is assessing APR-1051 as a monotherapy for patients with unmet medical needs, with active enrollment at three U.S. sites.
The ongoing clinical trial for APR-1051 signals potential advancements in treatment options, which could impact market value and investor interest in the associated biotech firm.
Frequently Asked Questions About APRE Stock
What is Clear Creek Independent School District's (APRE) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, Clear Creek Independent School District (APRE) has a median price target of $16.00. The highest price target is $20.00 and the lowest is $11.00.
Is APRE stock a good investment in 2025?
According to current analyst ratings, APRE has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.40. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for APRE stock?
Wall Street analysts predict APRE stock could reach $16.00 in the next 12 months. This represents a 566.7% increase from the current price of $2.40. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Clear Creek Independent School District's business model?
As a public school district, it generates revenue primarily through state funding, local property taxes, and grants. Its focus on delivering quality education and enhancing student outcomes allows it to maintain strong community support and partnerships, which further bolster its resources.
What is the highest forecasted price for APRE Clear Creek Independent School District?
The highest price target for APRE is $20.00 from Joseph Pantginis at HC Wainwright & Co., which represents a 733.3% increase from the current price of $2.40.
What is the lowest forecasted price for APRE Clear Creek Independent School District?
The lowest price target for APRE is $11.00 from Robert Driscoll at Wedbush, which represents a 358.3% increase from the current price of $2.40.
What is the overall APRE consensus from analysts for Clear Creek Independent School District?
The overall analyst consensus for APRE is bullish. Out of 7 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $16.00.
How accurate are APRE stock price projections?
Stock price projections, including those for Clear Creek Independent School District, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
